QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lexaria-awarded-4-new-patents-covering-therapeutics-for-diabetes-hypertension-seizure-disorders-and-antiviral-treatments

Lexaria is pleased to announce that it has been awarded 4 new patents, continuing to build upon our already significant intelle...

 nasdaq-gains-100-points-us-consumer-sentiment-falls

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow ...

Core News & Articles

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

 dow-jumps-over-250-points-feds-key-inflation-gauge-remains-hot

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0...

 lexaria-bioscience-prices-4m-registered-direct-offering-at-150share-with-137-warrants-in-concurrent-private-placement

Lexaria Bioscience Corp. (NASDAQ:LEXX, LEXXW))) (the "Company" or "Lexaria"), a global innovator in drug delive...

 why-top-kingwin-shares-are-trading-higher-by-87-here-are-20-stocks-moving-premarket

Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales ...

 why-are-lexaria-bioscience-shares-soaring-45-after-hours

Lexaria Bioscience Corp. (NASDAQ: LEXX) experienced a dramatic 45.10% surge in after-hours trading on Thursday, climbing to $2....

 effective-september-19-2025-lexaria-bioscience-terminated-the-capital-on-demand-sales-agreement-with-jonestrading-institutional-services

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001348362/000164033425001717/lxrp_8k.htm

Core News & Articles

Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and EfficacyLexaria Bioscience Corp. (NA...

Core News & Articles

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug d...

 watching-lexaria-bioscience-zacks-small-cap-research-gives-stock-8-price-valuation

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_07312025_LEXX_Vandermosten.pdf

 hc-wainwright--co-maintains-buy-on-lexaria-bioscience-lowers-price-target-to-4

HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and lowers the price target fr...

Core News & Articles

DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastroint...

Core News & Articles

The fastest growing sector in the global pharmaceutical industry is struggling to face its most serious challenge: unwanted sid...

 lexaria-bioscience-q3-eps-021-misses-016-estimate-sales-174000k-beat-91333k-estimate

Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

 hc-wainwright--co-maintains-buy-on-lexaria-bioscience-lowers-price-target-to-5

HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and lowers the price target fr...

Core News & Articles

New patents received for the treatment of epilepsy and for the sublingual delivery of nicotineKELOWNA, BC / ACCESS Newswire / J...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION